Felix Lindberg

Publications
CV
Public outreach and news

Articles

Article: CIRCULATION. 2025;151(13):931-945
Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction
Basile C; Lindberg F; Benson L; Guidetti F; Dahlstrom U; Piepoli MF; Mol P; Scorza R; Maggioni AP; Lund LH; Savarese G
Article: ESC HEART FAILURE. 2024;12(2):900-911
Phenotyping patients with chronic obstructive pulmonary disease and heart failure
Becher PM; Lindberg F; Benson L; Hage C; Dahlstrom U; Rosenkranz S; Cosentino F; Rosano GMC; Blankenberg S; Kirchhof P; Braunschweig F; Lund LH; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2024;27(2):366-376
Trends in heart failure mortality in Sweden between 1997 and 2022
Lindberg F; Benson L; Dahlstrom U; Lund LH; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26(10):2243-2257
Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
Stolfo D; Benson L; Lindberg F; Dahlstrom U; Kack O; Sinagra G; Lund LH; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26(6):1408-1418
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
Savarese G; Lindberg F; Christodorescu RM; Ferrini M; Kumler T; Toutoutzas K; Dattilo G; Bayes-Genis A; Moura B; Amir O; Petrie MC; Seferovic P; Chioncel O; Metra M; Coats AJS; Rosano GMC
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26(6):1278-1297
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
Savarese G; Lindberg F; Cannata A; Chioncel O; Stolfo D; Musella F; Tomasoni D; Abdelhamid M; Banerjee D; Bayes-Genis A; Berthelot E; Braunschweig F; Coats AJS; Girerd N; Jankowska EA; Hill L; Lainscak M; Lopatin Y; Lund LH; Maggioni AP; Moura B; Rakisheva A; Ray R; Seferovic PM; Skouri H; Vitale C; Volterrani M; Metra M; Rosano GMC
Article: PLOS ONE. 2024;19(5):e0303348
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry
Lindberg F; Oigaard N; Metra M; Rosano GMC; Dahlstrom U; Mol P; Hage C; Lund LH; Savarese G
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.975
Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
Stolfo D; Lund L; Benson L; Kack O; Lindberg F; Sinagra G; Dahlstrom U; Savarese G
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(6):526-535
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
Stolfo D; Lund LH; Sinagra G; Lindberg F; Dahlstrom U; Rosano G; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(9):1648-1658
Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
Stolfo D; Lund LH; Benson L; Lindberg F; Ferrannini G; Dahlstrom U; Sinagra G; Rosano GMC; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(8):1418-1428
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry
Nguyen NV; Lindberg F; Benson L; Ferrannini G; Imbalzano E; Mol PGM; Dahlstrom U; Rosano GMC; Ezekowitz J; Butler J; Lund LH; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(8):1270-1280
Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative project
Lindberg F; Lund LH; Benson L; Linde C; Orsini N; Carrero JJ; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(11):2093-2104
Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry
Lindberg F; Lund LH; Benson L; Dahlstrom U; Karlstrom P; Linde C; Rosano G; Savarese G
Article: ESC HEART FAILURE. 2022;9(2):822-833
Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure
Lindberg F; Lund LH; Benson L; Schrage B; Edner M; Dahlstrom U; Linde C; Rosano G; Savarese G

All other publications

Editorial comment: EUROPEAN HEART JOURNAL. 2025;:1537-1539
Opportunities and challenges in preventing heart failure: when is risk modifiable?
Lindberg F; Savarese G
Editorial comment: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025;85(2):117-119
Worsening Heart Failure An Opportunity for Treatment Implementation Even With a Preserved Ejection Fraction?
Lindberg F; Savarese G
Doctoral thesis: 2024
Prognostication in heart failure across the ejection fraction spectrum : implications for clinical practice and trial design
Lindberg F
Review: DIABETOLOGIA. 2024;67(2):246-262
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Savarese G; Lindberg F; Filippatos G; Butler J; Anker SD
Letter: JAMA CARDIOLOGY. 2023;8(8):793
What Role for New York Heart Association Class in Heart Failure Clinical Trials?
Lindberg F; Tomasoni D; Savarese G
Conference publication: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023;81(8):321
IRON DEFICIENCY IN HEART FAILURE: SCREENING, PREVALENCE, INCIDENCE, IRON NEED, AND OUTCOMES
Lindberg F; Lund L; Benson L; Linde C; Orsini N; Carrero JJ; Savarese G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25:250
Iron deficiency in heart failure - prevalence, symptoms, functional capacity and health-related quality of life, and outcomes according to different definitions
Lindberg F; Lund LH; Linde C; Orsini N; Dahlstrom U; Savarese G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25:192
Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
Stolfo DD; Lund L; Benson L; Lindberg F; Dahlstrom U; Sinagra G; Rosano G; Savarese G
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:847
Association between use of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitors and beta-blockers and outcome in real-world heart failure and mildly reduced ejection fraction
Stolfo D; Lindberg F; Lund L; Sinagra G; Dahlstrom U; Rosano G; Savarese G
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:963
Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry
Nguyen VN; Lindberg F; Dahlstrom U; Lund LH; Savarese G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24:72
Trajectories in New York Heart Association functional class across the ejection fraction spectrum: data from the Swedish Heart Failure registry
Lindberg F; Lund LH; Dahlstrom U; Linde C; Rosano G; Savarese G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2021;23:66-67
Determinants of and association with outcomes of referral to specialty vs. primary care in patients with heart failure: data from the Swedish Heart Failure registry
Lindberg F; Lund LH; Benson L; Schrage B; Dahlstrom U; Savarese G

Employments

Postdoctoral Researcher, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2025-2026
Postdoctoral Researcher, Department of Medicine, Karolinska Institutet, 2024-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2024
Degree Of Master Of Science In Medicine, Karolinska Institutet, 2022

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI